Noji Takehiro, Tsuchikawa Takahiro, Okamura Keisuke, Tanaka Kimitaka, Nakanishi Yoshitsugu, Asano Toshimichi, Nakamura Toru, Shichinohe Toshiaki, Hirano Satoshi
Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.
J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):442-8. doi: 10.1002/jhbp.363. Epub 2016 Jun 9.
Whether concomitant hepatic artery resection (HAR) improves the prognosis for advanced perihilar cholangiocarcinoma remains controversial. The aim of the present study was to compare short- and long-term surgical results of HAR versus standard resection (SR) for perihilar cholangiocarcinoma using propensity score matching.
Among 209 patients with perihilar cholangiocarcinoma patients who underwent resection in our department, 28 patients underwent HAR, and the remaining 181 patients underwent SR. To adjust for differences in clinicopathological factors, including difficulty in surgery, between groups, propensity score matching was used at a 1:1 ratio, resulting in a comparison of 24 patients per group. The study protocols were approved by our institutional review board (015-0365), enrolled in UMIN-CTR (No: UMIN000019927), and conducted according to the Declaration of Helsinki.
No significant differences were seen in overall incidence of postoperative complications (Clavien-Dindo classification ≥IIIa: 37.5% in SR group vs. 62.5% in HAR group; P = 0.080), except for postoperative liver abscess formation (P = 0.020). Five-year overall survival rates were 30.3% and 20.4%, respectively. No significant difference in overall survival rate was apparent between the SR and HAR groups (P = 0.150).
Despite being a demanding procedure, concomitant HAR appears feasible for selected patients with perihilar cholangiocarcinoma.
肝动脉切除术(HAR)是否能改善肝门部胆管癌的预后仍存在争议。本研究旨在通过倾向评分匹配比较肝门部胆管癌患者接受肝动脉切除术与标准切除术(SR)的短期和长期手术结果。
在我院接受手术的209例肝门部胆管癌患者中,28例行肝动脉切除术,其余181例行标准切除术。为调整两组间包括手术难度在内的临床病理因素差异,采用1:1比例的倾向评分匹配,最终每组24例患者进行比较。本研究方案经我院伦理委员会批准(015 - 0365),并已注册于UMIN - CTR(编号:UMIN000019927),且按照《赫尔辛基宣言》进行。
除术后肝脓肿形成外(P = 0.020),术后并发症总体发生率无显著差异(Clavien - Dindo分级≥IIIa:标准切除组为37.5%,肝动脉切除组为62.5%;P = 0.080)。5年总生存率分别为30.3%和20.4%。标准切除组和肝动脉切除组的总生存率无显著差异(P = 0.150)。
尽管肝动脉切除术是一项要求较高的手术,但对于部分肝门部胆管癌患者而言似乎是可行的。